Research Coordinating Unit for Testing Multi-Level Interventions to Improve Blood Pressure Control in Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations

测试多层次干预措施以改善少数族裔/民族、社会经济地位低下和/或农村人口血压控制的研究协调单位

• 批准号: 9344670
• 负责人: Paula Darby Lipman
• 金额: $ 37.83万
• 依托单位: WESTAT, INC.
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-28 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9344670
• 关键词: Agreement; Area; Awareness; Cessation of life; Clinical Research; Clinical Trials; Clinical Trials Data Monitoring Committees; Communication; Communication Research; Communities; Coordinating Center Administration; Development; Diagnosis; Disease; Doctor of Philosophy; Elements; Evaluation; Evidence based intervention; Exclusion Criteria; Family; Funding; Goals; Health; Health Personnel; Hypertension; Individual; Intervention; Intervention Studies; Joints; Knowledge; Learning; Logistics; Methodology; Methods; Mission; Modeling; Myocardial Infarction; National Heart, Lung, and Blood Institute; Outcome Measure; Outcomes Research; Patient-Focused Outcomes; Patients; Persons; Preventive Medicine; Primary Health Care; Principal Investigator; Publications; Reporting; Research; Research Activity; Research Infrastructure; Research Institute; Research Personnel; Research Support; Risk; Rural Population; Site; Stroke; Subgroup; Testing; Time; Treatment outcome; U-Series Cooperative Agreements; United States National Institutes of Health; Vision; Work; base; blood pressure reduction; blood pressure regulation; comparative effectiveness; design; disorder risk; disparity reduction; effectiveness research; ethnic minority population; experience; health disparity; high risk population; improved; lifetime risk; low socioeconomic status; meetings; member; minority health; multidisciplinary; online resource; practice-based research network; pragmatic trial; premature; programs; public health relevance; racial and ethnic; racial minority; research data dissemination; response; rural area; standard of care; symposium; web site

 DESCRIPTION (provided by applicant): Westat is pleased to apply in response to RFA-HL-15-031 to serve as the Research Coordinating Unit (RCU) in support of the Hypertension Disparities Reduction Program Partnership (HDRPP) goals and the administrative, communication, and research activities required under this agreement. As a member of this research partnership, the RCU will work with UH2/UH3 investigators, program staff, and the Program Steering Committee (PSC) to establish and nurture a cooperative and productive learning culture committed to meeting the program's planning and implementation milestones, harmonizing design elements where feasible, and generating and sharing relevant evidence to stakeholders and consumers. The Clinical Trials Area of Westat has over 25 years' experience coordinating and conducting federally sponsored clinical research relevant to patients, healthcare providers, and policymakers. We have served as the coordinating center for many large, multi-site, and multidisciplinary clinical research programs across a broad range of health and disease focus areas. Westat's proposed RCU team offers strong logistical and technical capabilities, as well as a team of subject matter experts (SMEs) with in-depth appreciation of PCORI's mission and goals, knowledge of patient- centered outcomes research (PCOR), comparative effectiveness research (CER), and patient and stakeholder engagement principles, and an understanding of the complexity and challenges of community-based management of hypertension. Proposed Principal Investigator (PI) Paula Darby Lipman, PhD, has conducted intervention research with primary care practice-based research networks (PBRNs), collaborated on infrastructure building projects in PCOR, and is currently PI for the NHLBI Pragmatic Trials Evaluation and Administration Coordinating Center. She is joined by Westat experts in preventive medicine (Margot Krauss, MD), PCOR and stakeholder engagement methodology (Jennifer Huang, PhD), and health disparities and minority health (Brenda Leath, MHSA), and an experienced project manager, Ms. Lauren Laimon. The vision for the RCU is to support the HDRPP goal of reducing the gap in hypertension awareness, diagnosis, treatment, and outcomes among high-risk populations through the coordination of research- and communications- related activities between and among the investigators, the PSC, PCORI, and the National Institutes of Health.

 描述（由申请人提供）：Westat很高兴响应RFA-HL-15-031申请担任研究协调单位（RCU），以支持高血压差异减少计划合作伙伴关系（HDRPP）目标以及本协议项下要求的管理、沟通和研究活动。作为这一研究伙伴关系的一员，RCU将与UH 2/UH 3研究人员，项目工作人员和项目指导委员会（PSC）合作，建立和培养一种合作和富有成效的学习文化，致力于满足项目的规划和实施里程碑，在可行的情况下协调设计元素，并向利益相关者和消费者提供和分享相关证据。Westat的临床试验领域拥有超过25年的经验，协调和开展与患者，医疗保健提供者和政策制定者相关的联邦资助的临床研究。我们曾担任协调中心，许多大型，多地点，多学科的临床研究计划，在广泛的健康和疾病的重点领域。Westat提议的RCU团队提供强大的后勤和技术能力，以及主题专家（SME）团队，他们深入了解PCRI的使命和目标，了解以患者为中心的结局研究（PCOR），比较有效性研究（CER）以及患者和利益相关者参与原则，并了解以社区为基础的高血压管理的复杂性和挑战。拟议的主要研究者（PI）Paula达比Lipman博士与基于初级保健实践的研究网络（PBRN）进行了干预研究，在PCOR的基础设施建设项目上进行了合作，目前是NHLBI实用试验评估和管理协调中心的PI。她与Westat的预防医学专家（Margot Krauss，医学博士），PCOR和利益相关者参与方法（Jennifer Huang，博士），健康差距和少数群体健康（Brenda Leath，MHSA）以及经验丰富的项目经理Lauren Laimon女士一起工作。区域协调股的愿景是通过协调研究者、PSC、PCORI和美国国立卫生研究院之间的研究和交流相关活动，支持HDRPP缩小高血压认知、诊断、治疗和高危人群结局方面的差距的目标。